Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma

Author：          

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|2|1171-1175

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.2, 2015-01, pp. : 1171-1175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CYP2C19 polymorphisms in patients with gastric and colorectal carcinoma

By Tamer L.  

International Journal of Gastrointestinal Cancer, Vol. 37, Iss. 1, 2006-02 ,pp. : 1-5

Humana Press, Inc

Access to resources Recommend Favorite

CYP2C19 genotype–phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity

By Burns K.   Goldthorpe M.   Porteus F.   Browett P.   Helsby N.  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 651-655

Springer Publishing Company

Access to resources Recommend Favorite

Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

By Szturz Petr  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1324-1326

Informa Healthcare

Access to resources Recommend Favorite

Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population

By Islam Mohammad   Mostofa A.   Ahmed Maizbha   Sayeed Muhammad   Hassan Md.   Hasnat Abul  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1671-1678

Springer Publishing Company

Access to resources Recommend Favorite

RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients

By                      

Oncology Reports, Vol. 34, Iss. 4, 2015-01 ,pp. : 1883-1894

Spandidos Publications

Access to resources Recommend Favorite